Drawing for BIOCARESD CONNECT

USPTO serial 88394256

BIOCARESD CONNECT

Reviewed by CopyMark Law Group

Reg. 6049260Status 700Renewal
Filing date
Status date
Registration date
May 5, 2020
Examiner
PIERCE, ALEXANDRA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIOCARESD CONNECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Emily A. Bayton

Emily A. Bayton Faegre Baker Daniels LLP90 South Seventh Street2200 Wells Fargo CenterMinneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
035Consignment inventory services, namely, inventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician officesACTIVEJan 24, 2020
039Distribution services, namely, delivery of therapeutic plasma-derivatives and recombinant coagulation products used for hemophilia and thrombophilia treatment, immunology, wound management, and critical care; biopharmaceutical and specialty pharmaceutical distribution services, namely, transport, delivery, packaging and storage of therapeutic plasma-derivatives and recombinant coagulation products for hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician officesACTIVEJan 24, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 5, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 28, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 8, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 8, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 19, 2020IUAFUSE AMENDMENT FILED—
Feb 19, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 19, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 19, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 19, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 19, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 1, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 6, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 6, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 28, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 27, 2019DOCKASSIGNED TO EXAMINER—
Jun 11, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 6, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 23, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance